AlbertLaiMDPhD
Neurology • Los Angeles, CANeurooncology
Assistant Professor, Neurology, UCLA School of Medicine
Are you Dr. Lai?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 93 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
300 Medical Plz
Suite B200
Los Angeles, CA 90095Phone+1 310-794-1195Fax+1 310-794-7491
Summary
- Dr. Albert Lai, MD is a board certified neurologist in Los Angeles, California. He is currently licensed to practice medicine in California. He is affiliated with Ronald Reagan UCLA Medical Center and is an Assistant Professor at UCLA School of Medicine.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Neuro-Oncology, 2002 - 2005- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1999 - 2002
Adventist Health White MemorialInternship, Internal Medicine, 1998 - 1999
University of California San Diego School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - 2025- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2011 Oct 03
- Bevacizumab, Temozolomide, and External Beam Radiation Therapy as First-Line Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma Start of enrollment: 2006 Jun 01
Publications & Presentations
PubMed
- 45 citationsMetabolic characterization of isocitrate dehydrogenase (IDH) mutant and IDH wildtype gliomaspheres uncovers cell type-specific vulnerabilities.Matthew C. Garrett, Jantzen Sperry, Daniel Braas, Weihong Yan, Thuc Le
Cancer & Metabolism. 2018-04-17 - 47 citationsResponse Classification Based on a Minimal Model of Glioblastoma Growth Is Prognostic for Clinical Outcomes and Distinguishes Progression from PseudoprogressionMaxwell Lewis Neal, Andrew D. Trister, Sunyoung Ahn, Anne Baldock, Carly Bridge
Cancer Research. 2013-05-15 - 56 citationsLarge-scale assessment of the gliomasphere model systemDan R. Laks, Thomas J. Crisman, Michelle Y. S. Shih, Jack Mottahedeh, Fuying Gao
Neuro-Oncology. 2016-10-01
Press Mentions
- Preferential Tumor Localization in Relation to 18F-FDOPA Uptake for Lower‐Grade GliomasMarch 11th, 2021
Relative Oxygen Extraction Fraction (rOEF) MR Imaging Reveals Higher Hypoxia in Human Epidermal Growth Factor Receptor (EGFR) Amplified Compared with Non-Amplified GliomasOctober 26th, 2020
Impact of Dementia Risk Factors May Vary by Race and Ethnicity, Study FindsOctober 19th, 2023
